The DOI matches its Crossref record; 116 of the 117 references it cites were found in a registry or an index; 9 of the 58 sources its claims cite were checked for support.
Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease
Open accessAbstract
Alzheimer's disease (AD) is characterized by progressive cognitive decline associated with a featured neuropathology (neuritic plaques and neurofibrillary tangles). Several studies have implicated oxidative damage to DNA, DNA repair, and altered cell-cycle regulation in addition to cell death in AD post-mitotic neurons. However, there is a lack of studies that systematically assess those biological processes in patients with AD neuropathology but with no evidence of cognitive impairment. We evaluated markers of oxidative DNA damage (8-OHdG, H2AX), DNA repair (p53, BRCA1, PTEN), and cell-cycle (Cdk1, Cdk4, Cdk5, Cyclin B1, Cyclin D1, p27Kip1, phospho-Rb and E2F1) through immunohistochemistry and cell death through TUNEL in autopsy hippocampal tissue samples arrayed in a tissue microarray (TMA) composed of three groups: I) "clinical-pathological AD" (CP-AD)--subjects with neuropathological AD (Braak ≥ IV and CERAD = B or C) and clinical dementia (CDR ≥ 2, IQCODE>3.8); II) "pathological AD" (P-AD)--subjects with neuropathological AD (Braak ≥ IV and CERAD = B or C) and without cognitive impairment (CDR 0, IQCODE<3.2); and III) "normal aging" (N)--subjects without neuropathological AD (Braak ≤ II and CERAD 0 or A) and with normal cognitive function (CDR 0, IQCODE<3.2). Our results show that high levels of oxidative DNA damage are present in all groups. However, significant reductions in DNA repair and cell-cycle inhibition markers and increases in cell-cycle progression and cell death markers in subjects with CP-AD were detected when compared to both P-AD and N groups, whereas there were no significant differences in the studied markers between P-AD individuals and N subjects. This study indicates that, even in the setting of pathological AD, healthy cognition may be associated with a preserved repair to DNA damage, cell-cycle regulation, and cell death in post-mitotic neurons.
Overview
CoChat Summary
TL;DR
In autopsy hippocampal tissue, subjects with AD neuropathology and clinical dementia (CP-AD) showed reduced DNA-repair/cell-cycle-inhibition markers and increased cell-cycle-progression and cell-death markers compared with both pathological AD without cognitive impairment (P-AD) and normal aging (N). P-AD subjects were largely indistinguishable from N subjects, suggesting preserved DNA repair and cell-cycle control may accompany resilient cognition despite AD pathology.
Key findings
- Oxidative DNA damage markers were elevated in CP-AD versus N: nuclear 8-OHdG median 25 vs 15 (Dunn p=0.0145) and nuclear H2AX median 20 vs 7 (p=0.0001); high damage was present in all groups.
- Nuclear DNA-repair markers were lower in CP-AD than in P-AD and N: p53 median 7 vs 14 and 15 (CP-AD vs N p<0.0001; CP-AD vs P-AD p=0.0222), and PTEN median 25 vs 31 and 27 (CP-AD vs P-AD p=0.0003; CP-AD vs N p=0.0093).
- Cell-cycle progression markers (Cdk4, cyclin D, phospho-Rb, E2F1, Cdk1, cyclin B) were higher in CP-AD than in P-AD and N, while inhibitors p27 and Cdk5 were lower in CP-AD; apoptosis was higher in CP-AD (median 20) than P-AD (3.5) and N (0).
- Hierarchical clustering separated all CP-AD samples from a combined P-AD + N cluster with 100% bootstrap support; P-AD and N showed no significant differences for the studied markers.
Methods
- Post-mortem hippocampal CA1 tissue from the Brain Bank of the Brazilian Aging Brain Study Group was arrayed in a tissue microarray; groups were CP-AD (neuropathological AD plus dementia), P-AD (neuropathological AD without cognitive impairment), and N (normal aging), with Table 1 listing 19 CP-AD, 12 P-AD, and 31 N subjects (TMA construction text says 18 CP-AD).
- Immunohistochemistry assessed oxidative DNA damage (8-OHdG, H2AX), DNA repair (p53, BRCA1, PTEN, phospho-AKT), and cell-cycle markers (Cdk1, Cdk4, Cdk5, cyclin B1, cyclin D1, p27Kip1, phospho-Rb, E2F1); TUNEL assessed cell death.
- Nuclear and cytoplasmic positivity/intensity were scored semiquantitatively; group comparisons used Kruskal-Wallis with Dunn’s tests, and hierarchical clustering used Pearson correlation with average linkage and bootstrap support.
Limitations
- The paper states that additional studies are required to better understand pathogenic mechanisms, especially early AD stages, and to uncover and validate resilience biomarkers.
- Evident from the text: small group sizes (19 CP-AD, 12 P-AD, 31 N in Table 1), analysis restricted to hippocampal CA1 tissue microarray cores, and semiquantitative manual immunohistochemistry scoring.
- Evident from the text: cross-sectional autopsy design cannot establish causality; the authors argue PMI effects are unlikely because groups did not differ significantly in PMI and intervals were under 24 hours.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
8 Valid · 0 Not valid · 34 Not checked · 56 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Among individuals who showed no overt evidence of cognitive impairment in the final assessment prior to death, post-mortem studies showed a significant proportion of subjects with neuropathological diagnoses of AD”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Introduction
What the sources say
- Not checked yetcites [9] J Price, 1999, Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease, Ann Neurol source
- Supportedcites [10] JL Price, 2009, Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease, Neurobiol Aging source
The Abstract (Results) reports that about 40% of nondemented individuals met some neuropathological criteria for AD, or about 20% under strict criteria, and that neither group had measurable cognitive impairment before death. The Results (Comparison of npAD and no-npAD cases) specifically refer to their last clinical assessment before death. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genes involved in oxidative stress and in DNA damage/repair were found to be coupled with AD neuropathology.”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Introduction
What the sources say
- Supportedcites [24] AR Silva, 2012, Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer’s disease, PLoS One source
The Abstract states that 'genes involved in energy metabolism, oxidative stress, DNA damage/repair, senescence, and transcriptional regulation were implicated with the neuropathology of AD,' directly matching the claim. The Discussion (AD neuropathology-related gene set) and Results (Gene Expression Profile Related to AD Pathology) reinforce this, listing negative regulation of reactive oxygen species metabolic process and DNA synthesis involved in DNA repair among the overrepresented categories in Braak >=IV / CERAD B-C subjects versus no-pathology controls. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies have reported alterations in DNA repair proteins (cell-cycle checkpoint proteins and tumor suppressors) of pathways involved in the repair of oxidative stress-induced lesions in patients with AD [28], [79].”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Discussion
What the sources say
- Partly supportedcites [28] P Katsel, 2013, Cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer’s disease, PLoS One sourceExperimental — accuracy not yet measured
The paper does report alterations in cell-cycle checkpoint proteins and tumor suppressors in AD brain: the Introduction lists prior reports of changed CCL marker expression (including BRCA1, p16, p27, RB) in cortical neurons of persons with AD, and its own Results/Discussion show upregulated MDM4, ATM and ATR with declining TIGAR in STG of AD-dementia cases, described as an activated 'ATM signaling and DNA damage response network'. However, the source's own 'Recent studies have reported' sentence (Abstract > Background) credits checkpoint proteins and tumor suppressors such as ATM and p53 with controlling glycolysis and oxidative metabolism in cancer and states 'their involvement in AD remains uncertain', and the Discussion frames the DNA-damage response as repair of double-strand breaks, with the oxidative-stress link only 'a plausible association' (ATM 'may' link ROS damage to cell-cycle reactivation, loss of TIGAR-mediated protection). So the claim's assertion that these pathways repair oxidative stress-induced lesions in AD patients is presented more firmly than the source, which hedges that connection. (LLM, conf=0.70)
- Not checked yetcites [79] Bucholtz N, Demuth I (2013) DNA-repair in mild cognitive impairment and Alzheimer’s disease. DNA Repair (Amst). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Yang et al. [34] showed that in brains of people who died with MCI, the percentage of hippocampal neurons positive for cell-cycle proteins (PCNA, cyclin D and cyclin B) was very close to that found in individuals who died in advanced stages of AD (demented).”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Discussion
What the sources say
- Partly supportedcites [34] Y Yang, 2003, Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease, J Neurosci sourceExperimental — accuracy not yet measured
Yang et al. (2003) do report the similarity the claim rests on: the Abstract and the Cell counts section state that in hippocampus the percentages of cell cycle-immunopositive neurons in MCI 'were similar to those found in the AD cases' and far above controls (Table 2: cyclin D 5.2% vs 6.3%, PCNA 7.0% vs 7.1%), and cyclin B 'showed comparable levels of staining in both MCI and AD'. However, the comparison group is not characterized as advanced-stage AD: the Fig. 2 legend describes the AD material as 'subjects who died with mild to moderate AD', and Table 1 shows only 5 of 9 AD cases at Braak V-VI (mean MMSE 18.2, range 3-25), so the 'died in advanced stages of AD' qualifier is not what this source states. Additionally, cyclin B is reported only qualitatively as comparable staining (Fig. 3), not as a tabulated percentage of positive hippocampal neurons like PCNA and cyclin D. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“recent data have suggested a crucial role for Cdk5 as a cell-cycle suppressor in post-mitotic neurons.”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Discussion
What the sources say
- Supportedcites [103] J Zhang, 2010, Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex, J Neurosci source
The INTRODUCTION states outright that 'Cdk5 also plays a crucial role in neuronal cell cycle control,' with loss of Cdk5 causing failure of cell cycle suppression in Cdk5−/− neurons, and frames the work as understanding 'the factors that maintain a mammalian neuron in its post-mitotic state.' The Abstract calls Cdk5 'a potent cell cycle suppressor' and the DISCUSSION reiterates that 'nuclear Cdk5 acts as a cell cycle suppressor both in vivo and in vitro.' The hedged 'recent data have suggested' is therefore supported by a source making the point with equal or greater confidence; the only mild caveat is that the paper's own new experiments are in N2a cells and E14.5 embryonic progenitors, with the post-mitotic-neuron evidence resting on its prior work (Cicero and Herrup, 2005; Zhang et al., 2008) that this paper reports and relies on. (LLM, conf=0.88)
- Not checked yetcites [104] J Zhang, 2012, Cdk5 levels oscillate during the neuronal cell cycle: Cdh1 ubiquitination triggers proteosome-dependent degradation during S-phase, J Biol Chem source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
66 more claims · 1 with their cited sources checked
Create a free account to see all 98 claims and to verify the 49 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“elevated phosphorylated histone γH2AX (H2A histone family member X) levels have been reported in the hippocampus and lymphocytes from AD patients, indicating an active DNA damage response [230,231].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [230]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Abstract
“there were no significant differences in the studied markers between P-AD individuals and N subjects.”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Results > Oxidative DNA Damage
“| Cyclin D | 7 (0–14) | 9 (0–15) | 0 (0–15) | 0.0072* | 0.3813 | 0.269 | 0.0056* |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“| N1 | M | 80 | 3 | 0 | 0 | 19.7 |”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“31 subjects without neuropathological AD (Braak≤II and CERAD 0 or A) and with normal cognitive function”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Women, n (%) | 16 (84.2) | 7 (61.5) | 16 (51.6) | 0.064b |”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Results
Reported 61.5 · recomputed 58.333333
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“hippocampal samples (CA1 region) from 62 subjects (18 CP-AD, 12 P-AD, and 31 N)”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Construction of Tissue Microarray
Reported 62 · recomputed 61
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“| CP-AD1 | F | 98 | 3 | B | 2 | 15.1 |”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“19 subjects with neuropathological AD (Braak≥IV and CERAD = B or C) and clinical dementia”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496 · cited 1×
“Among the studied biomarkers, BRCA1 is associated with a spectrum of functions related to the preservation of genome stability, such as the repair of oxidative damage to DNA [84,85].”
BackgroundRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Neurofibrillary tangles (NFTs) and neuritic plaques (NPs) were assessed by a skilled neuropathologist in accordance with the Braak stage system [55] and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) [56], respectively.”
MethodThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 1×
“Notably, phosphorylated Akt may enhance cell survival by blocking the function of proteins and apoptotic processes [95].”
BackgroundGlobal prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“Alzheimer’s disease (AD) is the most frequent cause of dementia in the elderly, accounting for approximately 70% of dementia cases [1,2].”
BackgroundMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 4×
“Based on pathological and clinical criteria, subjects were categorized into three groups: I) 19 subjects with neuropathological AD (Braak$IV and CERAD=B or C) and clinical dementia (CDR$2, IQCODE.3.8), termed ‘‘clinical-pathological AD’’ (CPAD); II) 12 subjects with neuropathological AD (Braak$IV and CERAD=B or C) and…”
MethodInfluentialTM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Moreover, elevated phosphorylated histone γH2AX (H2A histone family member X) levels have been reported in the hippocampus and lymphocytes from AD patients, indicating an active DNA damage response [230,231].”
BackgroundMicroglial/Macrophage Polarization Dynamics following Traumatic Brain Injury
Kumar, A., Alvarez-Croda, D.-M., Stoica, B. A., Faden, A. I., & Loane, D. J. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4268 · Cited by 339
“inhibition, we assessed H2AX expression in the peri-lesional cortex, which is a marker of oxidative stress-induced DNA damage.(25)”
MethodFragile X-associated tremor/ataxia syndrome — features, mechanisms and management
Hagerman, R. J., & Hagerman, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.82 · Cited by 290
Cellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice
Suberbielle, E., Djukic, B., Evans, M., Kim, D. H., Taneja, P., Wang, X., Finucane, M., Knox, J., Ho, K., Devidze, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9897 · Cited by 202
“2c), consistent with previous reports 13,14 .”
Metadata
- Authors
- Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., de Bragança Pereira, C. A., Jacob-Filho, W., & Brentani, H.
- Affiliations
- Universidade de São Paulo (BR)
- AC Camargo Hospital (BR)
- Corresponding author
- Silva, Aderbal R. T.
- Grinberg, Lea T.
- Rocha, Rafael M.
- Carraro, Dirce M.
- Brentani, Helena
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-17
- Volume
- 9
- Issue
- 6
- Pages
- e99897
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4061071
- OpenAlex
- W2129162505
- Cited by
- 99
- References
- 117
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 15 · 2019: 4 · 2018: 13 · 2017: 9 · 2016: 11 · 2015: 7 · 2014: 1
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (11/01652-6, 2011/)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- Alzheimer's disease, oxidative DNA damage, DNA repair, cell cycle regulation, neuronal cell death, postmitotic neurons, hippocampus, 8-hydroxy-2'-deoxyguanosine, H2AX, p53, BRCA1, PTEN, cyclins, cyclin-dependent kinases, p27, E2F1, normal aging
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Cell Cycle, DNA Damage, DNA Repair, Female, Hippocampus, Humans, Male, Neurons, Apoptosis, Oxidative Stress, Tissue Array Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease. https://app.cochat.ai/papers/10.1371/journal.pone.0099897
- The paper
- Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., de Bragança Pereira, C. A., Jacob-Filho, W., & Brentani, H. (2014). Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0099897
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.